EXHIBIT 2.6
SECOND AMENDMENT TO
ASSET PURCHASE AGREEMENT
THIS SECOND AMENDMENT to that certain Asset Purchase Agreement dated
September 1, 1998 (the "Purchase Agreement") by and between GalaGen Inc., a
Delaware corporation ("Buyer"), and Nutrition Medical, Inc., a Minnesota
corporation ("Seller"), is made as of this 23rd day of December, 1998.
Capitalized terms not otherwise defined herein are used with the meaning given
such terms in the Purchase Agreement.
RECITALS
The Purchase Agreement provides for Buyer to acquire certain assets of
Seller subject to the terms and conditions thereof.
The Purchase Agreement was amended by an Amendment To Asset Purchase
Agreement (the "Amendment") dated as of September 28, 1998.
The Amendment provides that Buyer will pay to Seller an International
Royalty on certain sales of the Products. Buyer and Seller wish to further
specify in this Second Amendment the sales of the Products to which the
International Royalty applies.
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing recitals and the
mutual covenants and conditions contained herein, the parties do hereby amend
the Purchase Agreement as follows:
1. Section 2.2 is amended and restated in its entirety to read as follows:
2.2 INTERNATIONAL ROYALTY. Buyer will pay to Seller an international
royalty (the "International Royalty") (a) of five percent (5%) of net
International Sales (as defined herein), reduced by uncollectible accounts,
in excess of $200,000 during the year ending on the first anniversary of
the Closing Date, and (b) of two and one half percent (2 1/2%) of net
International Sales, reduced by uncollectible accounts, in excess of
$200,000 during the year ending on the second anniversary of the Closing
Date. Buyer will make payment, if any, of the International Royalty no
later than 120 days after the end of the year to which such royalty
relates, accompanied by such documentation as may be agreed upon by Buyer
and Seller. "International Sales" as used herein means sales made directly
by Buyer of the Product known as "Glutasorb Ready to Use" to customers in
all countries
except the United States, Japan, France, England, Scotland, Belgium,
Holland, Switzerland, Denmark, Sweden, Norway and Finland and sales made
directly by Buyer of all Products other than "Glutasorb Ready to Use" to
customers in all countries except the United States.
2. Except as expressly set forth herein, the terms and conditions of the
Purchase Agreement, as amended by the Amendment, remain unmodified and in
full force and effect.
3. This Second Amendment may be executed in counterparts, each of which shall
be considered an original.
IN WITNESS WHEREOF, the parties have caused this Second Amendment to
be executed by their duly authorized representatives to be effective as of the
date first given above.
NUTRITION MEDICAL, INC. GALAGEN INC.
By/s/ Xxxxxxx X. Xxxxxxxxx By/s/ Xxxx X. Xxxxxx
--------------------------------- --------------------------------------
Its Chief Operating Officer Its Chief Financial Officer
------------------------------ -----------------------------------
